AgMedica Bioscience Inc. Announces Receipt of Health Canada Approval for Phase Two Riverview Facility Expansion Project

Published: September 6, 2019

AgMedica Bioscience Inc. Announces Receipt of Health Canada Approval for Phase Two Riverview Facility Expansion Project

AgMedica Bioscience Inc., a licensed producer of cannabis for medicinal and adult-use consumers, is pleased to announce that it has received approval from Health Canada to extend its existing cultivation and processing license to phase two of its Riverview facility expansion. This approval will allow AgMedica to add a further 12 flowering rooms and increase the cultivation capacity of the facility to between 26,000 and 30,000 kg per year, more than tripling its current capacity.

Receipt of this approval represents another key milestone in AgMedica’s path toward becoming a global leader in the development and commercialization of cannabis and cannabis-derived products designed to support client health and wellness. Since late 2017, the Company has successfully secured the regulatory approvals required to harvest and sell cannabis, which has contributed to the ongoing growth and enhancement of the business.

“I am very pleased that AgMedica has received Health Canada approval for our phase two facility expansion,” said Dr. Trevor Henry, AgMedica’s CEO. “We gain nearly four times the productive capacity and are better positioned to continue helping improve the quality of life for all of our patients by providing superior, consistent, quality medication.”

In addition to the phase two expansion approval, the Company also confirms that on August 2, 2019, it was granted a medical sales license for its Heritage location, which enables AgMedica to better facilitate healthy living for its clients through a portfolio of products that includes CBD, THC and Balanced varieties.

As a licensed producer of medicinal cannabis, AgMedica is dedicated to becoming a global leader in the development and commercialization of cannabis and cannabis-derived products to support the health and wellness of our clients. We aspire to drive the evolution of the cannabis industry by focussing investment on the development and commercialization of differentiated products in the medicinal, health & wellness and pharmaceutical sectors.

Recent News

View All News Items

Latest Article

How Database Integrations Can Improve Every Step in Your Cannabis Supply Chain Labeling

How Database Integrations Can Improve Every Step in Your Cannabis Supply Chain Labeling

At any step in the cannabis supply chain, your labeling system should allow for full control and traceability, from seed to sale. Implementing lean principles and labeling best practices across the cannabis supply chain can help you streamline your seed-to-sale labeling process and help you gain control.

Click below to read the full blog and learn how to reduce waste, cut costs, and gain efficiency with cannabis labeling: https://bit.ly/2KwZ5IQ

Read Article